Castle Biosciences Operating Cash Flow 2011-2026 | CSTL

Annual Operating Cash Flow Castle Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
64.3 M	64.9 M	-5.63 M	-41.7 M	-19 M	9.86 M	7.02 M	-12.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.9 M	-41.7 M	8.44 M

Quarterly Operating Cash Flow Castle Biosciences

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-22.1 M	-	-	-6.04 M	-	-	-	-6.84 M	-	-	-	-25.4 M	-	-35.7 M	-30.4 M	-21.4 M	-	-16.2 M	-10.1 M	-3.63 M	-	10.3 M	13.2 M	-251 K	-	2.52 M	1.77 M	1.29 M	-	-9.08 M	-7.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.2 M	-35.7 M	-9.18 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Agilent Technologies A	1.48 B	$ 115.35	0.25 %	$ 35.1 B	USA
Celcuity CELC	-153 M	$ 133.1	-0.87 %	$ 6.22 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-29.1 M	$ 6.9	-24.26 %	$ 9.18 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-24.2 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Fulgent Genetics FLGT	-102 M	$ 17.55	-0.68 %	$ 540 M	USA
CareDx, Inc CDNA	42 M	$ 21.6	0.28 %	$ 1.15 B	USA
Guardant Health GH	-185 M	$ 125.53	4.74 %	$ 15.7 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	5.83 M	$ 1.8	-	$ 7.96 M	USA
ICON Public Limited Company ICLR	1.29 B	$ 116.97	2.74 %	$ 9.65 B	Irlanda
Illumina ILMN	837 M	$ 148.65	2.36 %	$ 23.6 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Lantheus Holdings LNTH	390 M	$ 99.78	-0.28 %	$ 6.73 B	USA
Genetic Technologies Limited GENE	-9.68 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	956 M	$ 1 091.39	-0.9 %	$ 22.5 B	Schweiz
Charles River Laboratories International CRL	738 M	$ 162.28	3.66 %	$ 8.04 B	USA
NeoGenomics NEO	5.23 M	$ 9.4	1.4 %	$ 1.2 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Medpace Holdings MEDP	713 M	$ 430.56	0.34 %	$ 12.4 B	USA
National Research Corporation NRC	26.4 M	$ 19.07	0.13 %	$ 427 M	USA
Natera NTRA	-432 M	$ 201.65	0.37 %	$ 19.8 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	1.8 M	$ 3.89	0.91 %	$ 360 M	USA
Personalis PSNL	-74.9 M	$ 9.19	2.74 %	$ 820 M	USA
Senseonics Holdings SENS	-59.1 M	$ 6.3	-2.05 %	$ 263 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Biomerica BMRA	-3.84 M	$ 2.38	-3.64 %	$ 5.47 M	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 65.39	0.8 %	$ 3.91 B	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 258.13	-0.11 %	$ 21.5 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 448.76	0.11 %	$ 169 B	USA
Waters Corporation WAT	653 M	$ 340.42	0.51 %	$ 20.3 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.67	2.95 %	$ 241 M	Irlanda
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 9.25	1.2 %	$ 2.01 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 193.95	0.54 %	$ 21.5 B	USA